9801:HK:HK-iShares Core MSCI China ETF (GBP)

ETF | Others |

Last Closing

USD 2.46

Change

-0.02 (-0.81)%

Market Cap

N/A

Volume

2.63K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-07 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
2800:HK Tracker Fund of Hong Kong

+0.02 (+0.11%)

USD 142.18B
2840:HK SPDR® Gold Shares

+2.50 (+0.15%)

USD 59.08B
2833:HK Hang Seng Index Tracking Fund

N/A

USD 30.97B
2828:HK Hang Seng China Enterprises In..

-0.06 (-0.09%)

USD 21.03B
2823:HK iShares FTSE A50 China

-0.09 (-0.70%)

USD 14.81B
3188:HK ChinaAMC CSI 300 Index ETF

-0.30 (-0.75%)

USD 14.60B
83188:HK ChinaAMC CSI 300 Index ETF

-0.20 (-0.54%)

USD 13.48B
2801:HK iShares Core MSCI China ETF

N/A

USD 11.74B
7226:HK CSOP Hang Seng TECH Index Dail..

-0.03 (-0.82%)

USD 10.25B
3067:HK iShares Hang Seng TECH ETF

-0.03 (-0.31%)

USD 9.22B

ETFs Containing 9801:HK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.14% 74% C 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.14% 73% C 72% C
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBP)

Quarterly Financials (GBP)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike